More than six years following the onset of the Covid pandemic, long Covid continues to affect millions of people globally. Recent research from a clinical trial led by University College London and University College London Hospitals examined potential treatments for the condition. The study investigated whether over-the-counter antihistamines combined with colchicine, a prescription anti-inflammatory medication, could provide relief. Results indicated these treatments produced a modest reduction in fatigue symptoms among long Covid patients, though researchers stressed the findings do not represent a cure for the condition.
Professor Danny Altmann, an immunologist at Imperial College London, provided perspective on the new research and discussed ongoing challenges in understanding long Covid. He highlighted additional studies currently underway that may contribute to improved comprehension and management of the condition going forward.
In related healthcare developments, data indicates approximately one in 335 people in the United Kingdom live with a stoma. However, according to Colostomy UK, more than 60 percent of individuals with a stoma report that inadequate toilet facilities negatively impact their daily functioning. A campaign originating in Bristol has resulted in B&Q retrofitting disabled toilets across its store locations to accommodate stoma-friendly features. The effort involved collaboration between retailer representatives and medical professionals, including colorectal surgeon Ms Caroline Burt from Bristol Foundation Trust.
Separately, claims circulating on social media have suggested ice cream consumption may reduce the risk of developing type 2 diabetes. Dr Sarah Berry, a nutritional scientist from King’s College London, examined these assertions to evaluate their scientific validity and address what some describe as the ‘ice cream paradox.’
Article Attribution | Read More at Article Source
Article summary produced by Claude AI